Human Brain Project in collaboration with BioExcel are organizing the HBP Annual Meeting.
Innovative neuromedicine approaches require a detailed understanding of the molecular and systems-level organisation of the human brain, the causes and mechanisms of diseases, their progression, and the response to treatments. Because of the high level of complexity of the nervous system and the inter-subject variability in molecular brain organisation, behaviour and disease, addressing these issues for any neuropathology appears a daunting task. Indeed, for most neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, there is currently no cure in spite of the very large investments from academia and industries. The discovery of new drugs against brain diseases is thus viewed as an ethical priority for ongoing neuroscience research.The aim of CDP6 is to develop new strategies for more effective drug treatments of brain diseases using computational models.
The detailed program can be found here.
- Silvia ACOSTA (UCL, London, UNITED KINGDOM)
- Katrin AMUNTS (FZ Jülich, GERMANY)
- Arnaud BLONDEL (Institut Pasteur, Paris, FRANCE)
- Riccardo CAPELLI (FZ Jülich, GERMANY)
- Adrien CERDAN (Institut Pasteur, Paris, FRANCE)
- Zoe COURNIA (Academy of Science, GREECE)
- Riccardo GUARESCHI (FZ Jülich, GERMANY)
- Achim KLESS (Grünenthal, Aachen, GERMANY)
- Daria KOKH (Heidelberg Institute for Theoretical Studies, GERMANY)
- Aurelien LUCIANI (IRB Barcelona, SPAIN)
- Luca MAGGI (FZ Jülich, GERMANY)
- Michael MARGREITER (FZ Jülich, GERMANY)
- Daniele NARZI (EPFL, Lausanne, SWITZERLAND)
- Bruce NEIL (Heidelberg Institute for Theoretical Studies, GERMANY)
- Modesto OROZCO (IRB Barcelona, SPAIN)
- Rebecca WADE (Heidelberg Institute for Theoretical Studies, GERMANY)
Venue: Building 16.15 (GRS building), Forschungszentrum Jülich (FZJ)
Find out more information on the conference here.